In our comprehensive study, network pharmacology analyses revealed that BBR could modulate the PI3K/AKT signalling pathway, thereby suppressing neuroinflammation, reducing oxidative damage and inhibiting lipidosis. Here, AKT1 is linked to lysosomal lipid storage disorder.